SCHEMBL27676402

SCHEMBL27676402

CC(=O)C1CC(C(=O)c2ccccc2)CN1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.42
CYP2D6 P10635 1/20 0.42
ALOX15 P16050 1/20 0.42
CYP2C19 P33261 1/20 0.42
SLC1A3 P43003 1/20 0.42
SLC1A2 P43004 1/20 0.42
SLC1A1 P43005 1/20 0.42
DPP4 P27487 4/20 0.40
CPB1 P15086 1/20 0.39
FAP Q12884 1/20 0.39
KCNH2 Q12809 1/20 0.37
HTR2A P28223 1/20 0.36
CES2 O00748 1/20 0.36
CES1 P23141 1/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
CHRNB2 P17787 1/20 0.36
CHRNB4 P30926 1/20 0.36
CHRNA3 P32297 1/20 0.36
CHRNA7 P36544 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5755300 0.87 CYP1A2 (0.58) CYP1A2CYP2D6ALOX15CYP2C19SLC1A3
SCHEMBL10860742 0.80 CYP1A2 (0.58) CYP1A2CYP2D6ALOX15CYP2C19SLC1A3
SCHEMBL27676384 0.80 KDM4E (0.42) CYP1A2CYP2D6CYP2C19MEN1KMT2A
SCHEMBL10860985 0.77 DPP4 (0.46) CYP1A2CYP2D6ALOX15CYP2C19SLC1A3
SCHEMBL10766797 0.77 ALDH1A1 (0.41) CYP1A2CYP2D6ALOX15CYP2C19SLC1A3
SCHEMBL11022918 0.77 DPP4 (0.50) CYP1A2CYP2D6ALOX15CYP2C19SLC1A3
SCHEMBL6567240 0.77 MAPT (0.45) ALOX15CYP2C19CPB1CES2CES1
SCHEMBL27676387 0.76 PTGS2 (0.48) CYP2D6CYP2C19KCNH2
SCHEMBL9422341 0.74 MGLL (0.38) ALOX15CPB1HTR2AMEN1KMT2A
SCHEMBL10621528 0.74 DPP4 (0.49) CYP1A2CYP2D6ALOX15CYP2C19SLC1A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1902172-A N-acylated-3- (benzoyl) - pyrrolidines as 11-beta-hsd1 inhibitors useful for the treatment of metabolic disorders ASTRAZENECA AB (SE) 2007-01-24 CN claimed
CN-1902172-A N-acylated-3- (benzoyl) - pyrrolidines as 11-beta-hsd1 inhibitors useful for the treatment of metabolic disorders ASTRAZENECA AB (SE) 2007-01-24 CN disclosed